- Home
- NXL vs AEHL Comparison
NXL vs AEHL Comparison
Compare NXL & AEHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXL
- AEHL
- Stock Information
- Founded
- NXL 2010
- AEHL 1993
- Country
- NXL United States
- AEHL China
- Employees
- NXL N/A
- AEHL N/A
- Industry
- NXL Medical Specialities
- AEHL Building Materials
- Sector
- NXL Health Care
- AEHL Industrials
- Exchange
- NXL Nasdaq
- AEHL Nasdaq
- Market Cap
- NXL 17.8M
- AEHL 17.3M
- IPO Year
- NXL 2022
- AEHL 2007
- Fundamental
- Price
- NXL $1.52
- AEHL $3.02
- Analyst Decision
- NXL Strong Buy
- AEHL
- Analyst Count
- NXL 1
- AEHL 0
- Target Price
- NXL $5.00
- AEHL N/A
- AVG Volume (30 Days)
- NXL 10.4M
- AEHL 164.2K
- Earning Date
- NXL 11-07-2025
- AEHL 09-25-2025
- Dividend Yield
- NXL N/A
- AEHL N/A
- EPS Growth
- NXL N/A
- AEHL N/A
- EPS
- NXL N/A
- AEHL N/A
- Revenue
- NXL $174,813.00
- AEHL $98,773,000.00
- Revenue This Year
- NXL $38.28
- AEHL N/A
- Revenue Next Year
- NXL $185.71
- AEHL N/A
- P/E Ratio
- NXL N/A
- AEHL N/A
- Revenue Growth
- NXL 16.42
- AEHL 36.99
- 52 Week Low
- NXL $0.70
- AEHL $1.79
- 52 Week High
- NXL $4.49
- AEHL $30.96
- Technical
- Relative Strength Index (RSI)
- NXL 61.70
- AEHL 41.84
- Support Level
- NXL $1.20
- AEHL $3.34
- Resistance Level
- NXL $1.46
- AEHL $4.36
- Average True Range (ATR)
- NXL 0.17
- AEHL 0.43
- MACD
- NXL 0.04
- AEHL -0.03
- Stochastic Oscillator
- NXL 57.89
- AEHL 9.49
About NXL Nexalin Technology Inc.
Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.
About AEHL Antelope Enterprise Holdings Limited
Antelope Enterprise Holdings Ltd operates in two reportable operating segments: 1) business management consulting, information system technology consulting services including the sales of software use rights for digital data deposit platforms and asset management systems, and online social media platform development and consulting, and 2) natural gas power generation, which was in the initial development stage. The business of the Company is engaged in the PRC and U.S.